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The ventral tegmental area (VTA) plays a central role
in the neural circuit control of behavioral reinforce-
ment. Though considered a dopaminergic nucleus,
the VTA contains substantial heterogeneity in neuro-
transmitter type, containing also GABA and gluta-
mate neurons. Here, we used a combinatorial viral
approach to transsynaptically label afferents to
defined VTA dopamine, GABA, or glutamate neu-
rons. Surprisingly, we find that these populations
received qualitatively similar inputs, with dominant
and comparable projections from the lateral hypo-
thalamus, raphe, and ventral pallidum. However,
notable differences were observed, with striatal re-
gions and globus pallidus providing a greater share
of input to VTA dopamine neurons, cortical input
preferentially on to glutamate neurons, and GABA
neurons receiving proportionally more input from
the lateral habenula and laterodorsal tegmental nu-
cleus. By comparing inputs to each of the trans-
mitter-defined VTA cell types, this study sheds
important light on the systems-level organization of
diverse inputs to VTA.
INTRODUCTION
The ventral tegmental area (VTA) and its cortical, striatal, and
limbic projections are key circuits involved in encoding, ener-
gizing, and adapting behavioral responses to salient stimuli. A
thorough understanding of the input-output VTA network is
required for our comprehension of addiction and other maladap-
tive behavioral disorders. Like many brain areas, cells in the VTA
do not represent a homogenous structure but are rather highly
heterogeneous, whether organized across anatomical, neuro-
chemical, or functional domains (Fields et al., 2007; Lammel
et al., 2014). One fundamental source of heterogeneity is the
neurotransmitter identity and the constellation of gene products
required to synthesize, package, release, and reuptake recycling
neurotransmitters. Althoughdopamine neurons in theVTAare the2796 Cell Reports 15, 2796–2808, June 21, 2016 ª 2016 The Author(
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abundant, as are neurons capable of co-releasing combinations
of these. The recent demonstration that VTA neurons express ve-
sicular glutamate transporter 2 (VGLUT2) (Kawano et al., 2006)
and the ability of some dopamine neurons to co-release gluta-
mate (Chuhma et al., 2014; Hnasko et al., 2010; Hnasko and Ed-
wards, 2012; Stuber et al., 2010; Tecuapetla et al., 2010) have led
to a surge of interest in VTA glutamate neurons. We and others
have begun to characterize their physiological properties, projec-
tion targets, and functional roles (Alsio¨ et al., 2011; Hnasko et al.,
2012; Root et al., 2014; Taylor et al., 2014). However, the afferent
inputs to VTA glutamate neurons and how the inputs compare to
VTA dopamine and GABA neurons remain unknown.
Retrograde tracing has been widely used to map sources of
afferent input from a target brain region. However, classical
tracers such as horseradish peroxidase or fluorogold do not
readily discriminate based on cell type. Several rabies- or her-
pes-based viral vectors have been developed that target genet-
ically defined cell types and spread transsynaptically to label
afferent inputs (Callaway, 2008; Card and Enquist, 2014; Osa-
kada et al., 2011; Wall et al., 2010; Wickersham et al., 2007).
Combined use of modified rabies virus (Rb) together with ‘‘help-
er’’ adeno-associated virus (AAV) vectors has proven particularly
amenable toward this goal across a variety of structures and
neuron types (Wall et al., 2013; Weissbourd et al., 2014). Indeed,
recent studies have used such approaches to characterize
inputs onto VTA or substantia nigra dopamine neurons (Beier
et al., 2015; Lerner et al., 2015; Menegas et al., 2015; Ogawa
et al., 2014; Watabe-Uchida et al., 2012).
Here, we compare the afferent inputs to genetically defined
VTA glutamate, dopamine, and GABA neurons using mCherry-
expressing and glycoprotein-deleted rabies virus pseudotyped
with an EnvA envelope protein (Osakada and Callaway, 2013).
This vector was used in combination with optimized helper
AAVs that allow for more accurate assessment of ‘‘starter cells,’’
enhancement of transsynaptic spreading, and titration to reduce
leakage. Our analysis of VTA inputs indicates that all the major
sources of VTA input target each of the transmitter-defined cell
types. For example, irrespective of VTA cell type, the dorsal
raphe (DR) and lateral hypothalamus (LH) provided the great-
est number of cells with afferent connections. Inputs to VTA
glutamate neurons were similar to inputs to VTA dopamines).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Strategy for Cell-Type-Specific Transsynaptic Tracing using Modified Rabies Virus
(A) Timeline of viral injections.
(B) Schematic illustrating strategy to achieve cell-type-specific transsynaptic tracing. Expression of TVA receptors (green) and RbG-hBFP (blue nuclei) is Cre
dependent. EnvA-Rb-DG-mCherry initially infects TVA-expressing cells and relies on RbG-hBFP expression for transsynaptic spread to afferent inputs.
Cre-positive starter cells are defined as those expressing both RbG (BFP) and Rb (mCherry).
(legend continued on next page)
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neurons, but glutamate cells received proportionally less input
from ventral striatal regions. Still largely similar, the VTA GABA
and dopamine neurons proved most distinct, with dopamine
neurons again receiving input from proportionally more striatal
neurons and GABA neurons receiving proportionally more from
lateral habenula (LHb) and hindbrain nuclei. By mapping the af-
ferents to each of the three major transmitter-defined VTA cell
populations, this study allows for a more thorough understand-
ing of the functional relevance of VTA inputs and outputs in
addiction and motivational processes.
RESULTS
Previous work has used Rb-based approaches to assess cell-
type-specific afferent inputs to midbrain dopamine neurons
(Beier et al., 2015; Lerner et al., 2015; Menegas et al., 2015; Wa-
tabe-Uchida et al., 2012). Here, we compare whole-brain inputs
to each of three populations of VTA cell types defined by their
recycling neurotransmitter. To define afferents to genetically
identified VTA glutamate neurons, we used knockin mice ex-
pressing Cre recombinase under the control of the Slc17a6
locus (vesicular glutamate transporter; VGLUT2-IRES-Cre). To
compare glutamate-releasing neurons with neighboring popula-
tions of dopamine or GABA neurons in the VTA, we used Slc6a3
(dopamine transporter; DAT-IRES-Cre) or Slc32a1 knockin mice
(vesicular GABA transporter, VGAT-IRES-Cre).
Strategy for Labeling Inputs to Defined VTA Cell Types
and Key Controls
To enable selective visualization of primary inputs to neurotrans-
mitter-defined populations, we used a modified Rb EnvA-Rb-
DG-mCherry (hereafter called Rb-mCherry) in combination with
two improved Cre-dependent helper viruses. Rb-mCherry was
modified to delete the rabies glycoprotein (RbG) from the viral
genome to prevent transsynaptic spreading and in its place in-
serted a mCherry fluorescent tag. To restrict initial cellular trans-
duction, Rb was pseudotyped with the avian sarcoma leukosis
virus coat protein EnvA, thus requiring the presence of an avian
TVA receptor for primary transduction. To allow for cell-type-
restricted transduction and subsequent transsynaptic propaga-
tion of themodified Rb,mice first received stereotactic injections
of two optimized helper AAV vectors. The first, AAV2/1-eSyn-
DIO-TVA950:YFP (hereafter referred to as AAV-TVA), allows
for initial cellular transduction of EnvA-pseudotyped Rb via
Cre-dependent expression of an avian TVA receptor fused with
yellow fluorescent protein (TVA:YFP). A second, AAV2/1-EF1a-
DIO-H2B-tagBFP-FLAGx3-T2Am-cB19G (hereafter referred to
as AAV-RbG), was mixed with the first and permits retrograde
transsynaptic spread by driving Cre-dependent co-expression
of the RbG plus a nuclear reporter. To increase efficiency of(C) Native Rb-mCherry and RbG:BFP fluorescence in sagittal sections from Cre-e
Scale bars represent 2.5 mm (left) and 250 mm (right).
(D) Percentages of starter cells present within and outside of the VTA.
(E) Unadjusted (raw) counts of the total number of input cells (±SEM).
(F) Ratio of input cell counts to starter cell counts (±SEM).
(G) Scatterplots of input cell counts and starter cell counts. Points represent indi
See also Figures S1 and S2.
2798 Cell Reports 15, 2796–2808, June 21, 2016transsynaptic spreading and reliably detect starter cells, we
made three modifications to the H2B-GFP-F2A-B19G cassette
used in previous studies (Osakada et al., 2011). The cassette
H2B-tagBFP-FLAGx3-T2Am-cB19G included (1) codon optimi-
zation to increase RbG expression for trans-complementation
of Rb-DG, (2) a distinctly colored FLAG-tagged histone-bound
blue fluorescent protein (BFP) for labeling starter cells, and (3)
enhanced multicistronic expression using the improved 2A
element T2Am. Three weeks after delivery of the helper virus to
the VTA, Rb-mCherry was injected at the same site to infect pri-
mary Cre-expressing starter cells in the VTA. One week later,
mice were sacrificed and whole brains sectioned to identify in-
puts (Figures 1A and 1B).
However, to verify the specificity of the strategy, we performed
three essential control experiments. First, to determine if the
modified Rb-mCherry relies exclusively on TVA for initial cellular
transduction, we injected Rb-mCherry without prior injection of
the helper AAVs. This is an important control to ensure that
each batch of pseudotyped Rb is not functionally contaminated
with RbG-coated Rb, although we confirmed no infection of
HEK293t cells with the EnvA-pseudotyped Rb-mCherry used
for in vivo injection. In five animals injected and brains sectioned,
we never detected mCherry+ cells (Figure S1A), demonstrating
that the EnvA pseudotyping entirely prevented Rb-mCherry en-
try absent cellular TVA expression.
Leakage of the TVA-expressing helper virus in non-Cre-ex-
pressing cells was encountered in previous studies (Watabe-
Uchida et al., 2012). Even though leak TVA expression may be
undetectable by immunochemistry, it can be revealed by our
second control experiment where we injected both AAV helpers
at ‘‘stock’’ concentrations (i.e., greater than 2 3 1012) into Cre-
negative wild-type (WT)mice prior to injection of the Rb-mCherry
(n = 2). InWTmice, we observed substantial mCherry+ cells in the
VTA (Figure S1B). This, despite no observed TVA:YFP (or hBFP)
fluorescence (Figure S1B), suggests a very low ‘‘leak’’ expres-
sion of TVA:YFP independent of Cre-mediated recombination,
thereby allowing for Rb entry via high-affinity interaction of TVA
with EnvA followed by Rb amplification. Importantly, and consis-
tent with previous observations, we saw no evidence of Rb-
driven mCherry expression outside of the immediate injection
sites, indicating that transsynaptic spread does not occur absent
robust RbG expression. Nonetheless, the presence of large
numbers of mCherry+ cells near the injection site in WT mice
limits identification of local or proximal connections. Because
very little TVA expression is required for initial transduction, we
reasoned that dilution of the AAV-TVA would allow us to identify
conditions under which injection into WT mice led to few
mCherry+ cells, while injection into Cre-expressing mice led
to labeling of many cells. Indeed, a 1:2,000 dilution of stock
AAV-TVA (i.e., 200 nl at 2.4 3 1010 genomes/ml) led to minimalxpressing mouse lines. White boxes and higher-power images represent VTA.
vidual animals, and lines represent linear regressions.
mCherry-labeling in the VTA of WT controls (Figure S1B) in com-
parison to Cre+ mice (Figure 1C).
In some circuits, some preparations of AAV can drive gene
expression in afferent populations of neurons, presumably by
AAV transduction of terminals and retrograde transport to cell
bodies (Castle et al., 2014;Menegas et al., 2015;Watabe-Uchida
et al., 2012). It is thus possible that Cre+ cells that project to VTA
may express low levels of TVA via the retrograde AAV mecha-
nism. Even low levels of TVA, if trafficked to nerve terminals in
the VTA, may allow for Rb transduction andmCherry expression.
Such a phenomenon would invalidate our ability to define inputs
to specific VTA cell types, because VGLUT2-Cre+ or VGAT-Cre+
neurons in afferent regions could express mCherry irrespective
of which cell type they target. Thus, for our third control experi-
ment, we injected diluted AAV-TVA without the second helper,
AAV-RbG, into groups of VGLUT2-, DAT-, or VGAT-Cre mice
(n = 3/genotype). Three weeks later, we injected Rb-mCherry
and, as expected, observedmCherry+ cells in the VTA. However,
in regions known to receive input from VTA neurons, we identi-
fied only mCherry+ fibers (Figure S1C); no mCherry-expressing
cell bodies were detected distal to the site of injection (Fig-
ure S1C). We therefore conclude that using our conditions, any
retrograde transport of AAV-TVA is insufficient to allow for direct
Rb-mCherry transduction following VTA injection.
Identification of VTA ‘‘Starter’’ Cell Types Defined by
Transmitter
Mice expressing Cre under the control of VGLUT2 (n = 6), DAT
(n = 6), or VGAT (n = 5), as well as WT mice (n = 4) were each in-
jected with diluted AAV-TVA and AAV-RbG into the VTA. Three
weeks later, they were injected with Rb-mCherry into the same
location and sacrificed 1 week later (Figure 1A). Starter cells
were identified as cells expressing both the RbG (defined as nu-
clear hBFP+) and mCherry (Figure 1C). We defined starter cells
thus because it is the expression of the RbG that allows Rb to
shed and spread transsynaptically. Zero starter cells were de-
tected in WT mice, and mice with starter cells best restricted
to VTA were included in the cell counts (n = 3–4 per genotype)
(Figures 1D and 2). In all included cases, >90% of starter cells
were located within the VTA (Data S1). Anatomical specificity
of the starter cell population was important for all cell types but
arguably most critical for the VGAT-Cre mice, where spread
into the GABA-neuron-rich interpeduncular nucleus (IP) led to
massive Rb-mCherry expression in the medial habenula (MHb)
(Figure S2). Though an equivalent number of starter cells were
labeled across the three genotypes, VTA glutamate neurons ap-
peared to receive more inputs per starter cells (27.8 ± 5.1 input
cells/starter cell) thanGABA neurons (14.1± 0.9), with VTA dopa-
mine neurons intermediate (20.8 ± 3.7) (Figures 1F and 1G).
To verify that starter cells appropriately represented trans-
mitter-defined cell types, we stained sections through the VTA
for the dopamine neuron marker tyrosine hydroxylase (TH).
Because native BFP fluorescence was particularly sensitive
to immunohistochemical procedures and showed more pro-
nounced photobleaching upon imaging, we co-labeled for the
FLAG epitope to better visualize nuclear BFP expression. As
expected, 97.6% ± 1.2% of starter cells in DAT-Cre mice were
TH+ (Figures 2B and 2E). We found that 18.4% ± 4.5% ofVGLUT2-Cre starter cells were TH+ (Figures 2A, 2E, and 2F),
consistent with numerous reports demonstrating overlap of TH
with VGLUT2 expression and co-release of dopamine with gluta-
mate (Hnasko et al., 2010; Hnasko et al., 2012; Stuber et al.,
2010; Yamaguchi et al., 2011). Finally, consistent with previous
evidence demonstrating that canonical GABAergic markers do
not appreciably co-localize with dopaminergic markers (Chieng
et al., 2011), only 0.3% ± 0.2% of the VGAT-Cre starter cells
were TH+ (Figures 2C and 2E).
Identification of Inputs to Transmitter-Defined VTA Cell
Types
To assess input cell numbers, we manually counted mCherry+
cells throughout the rostro-caudal axis of the brain, sampling
every fifth 30-mm section from Bregma +2.8mm to 5.8mm.
Macrostructure features and DAPI counterstain were used to
classify mCherry+ cells by brain region according to the Paxinos
mouse brain Atlas (Paxinos and Franklin, 2001). Brain regions
were then organized into sub-area and area. For example, nu-
cleus accumbens core (region) is included in the ventral striatum
(sub-area) of the striatum (area). mCherry+ cells detected in the
VTA itself and in regions directly surrounding the VTA, that is,
the substantia nigra pars compacta (SNc), interpeduncular
nucleus (IP), and red nucleus (R) (Data S1) were excluded from
the total input cell count because we could not distinguish cells
expressing low levels of TVA, and thus competent for direct
infection by injected Rb-mCherry, from cells making local con-
nections. Cells detected in the MHb were not included in this
analysis, as the presence of a small number of starter cells in
the IP (specifically in VGAT-Cre animals) led to large numbers
of mCherry-labeled cells in the MHb (Figure S2).
Examples of major inputs across cell type are shown in Fig-
ure 3. Compared to other cell types, VTA glutamate neurons
received more input per starter cell from cortex, dopamine neu-
rons received more inputs per starter cell from striatum, and
GABA neurons tended to receive less input overall when consid-
ered as a function of starters (Figure 3H). However, interpretation
of input data normalized by starter cells is complicated by the
distinct possibility of convergent inputs, resulting in fewer inputs
per starter cell as the number of starter cells increase. This can
be visualized as shallower slopes, notably for inputs/starter to
VTA GABA neurons (Figures 3A–3G). Thus, we also calculated
the total fraction of input each cell type receives as a fraction
of all inputs to that cell type; e.g., calculating that just 3.6% ±
0.3% of all inputs to dopamine neurons come from cortical re-
gions. These data can then be represented and considered in
a variety of ways, although it is essential to hold in mind that
the number of cells making afferent connections (inputs) to a
defined VTA cell type need not denote functional significance.
Spreadsheets with all cell counts broken down by brain areas,
sub-areas, and regions are provided in Data S1.
We found that all of themain inputs to VTAproject to each of the
transmitter-defined cell types (Figures 4A and 4B). These results
are consistent with recent observations by others examining in-
puts to projection-target defined dopamine neurons (Beier et al.,
2015; Watabe-Uchida et al., 2012) and indicate that inputs to the
VTA are not qualitatively constrained by VTA cell type. However,
evenat themacro level ofbrainarea,quantitativedifferencesbeginCell Reports 15, 2796–2808, June 21, 2016 2799
Figure 2. Localization of Starter Cells within VTA
(A–D) Representative coronal images of starter cells contained within VTA. Native Rabies-mCherry fluorescence is shown in red. Immunolabeling was used to
better visualize RbG-expressing cells that co-express the histone-bound FLAG-tagged BFP as shown in blue. Costaining to identify TH-expressing dopamine
neurons (green). Arrows represent triple-labeled cells, i.e., starter cells that co-localize for TH. Scale bars represent 200 mm (top) and 50 mm (bottom).
(E) Proportion of starter cells that label for TH across genotype (±SEM).
(F) Cell counts of TH-negative and TH-positive starter cells for each of the four VGLUT2-Cre mice used in this study.to emerge. For example, VTA dopamine neurons receive a higher
proportion of their input from striatal areas, whereas VTA GABA
neurons receive a greater proportion of their input from thalamic
and hindbrain regions (Figures 4A and 4B). These data also indi-
cate that most afferent control over VTA neurons arises from
outside the telencephalon. For example, the midbrain, hindbrain,
and hypothalamus represent a combined 68% ± 3%, 75% ±
3%, and 78% ± 1% of all inputs to, respectively, VTA dopamine,
glutamate, orGABAneurons.Of course, these brain areas include
many sub-areas, each composed of multiple discrete regions,
many of which are themselves heterogeneous.
Dissecting these macro brain areas into the 25 sub-areas and
regions that provided the greatest share of input (i.e., 75%–80%
of the total VTA input) revealed additional distinctions (Figures
4C, 4D, and 5). For example, each of the three striatal regions2800 Cell Reports 15, 2796–2808, June 21, 2016examined as well as the globus pallidus (LGP) preferentially
targeted dopamine neurons. Cortical regions tended to prefer-
entially target VGLUT2+ neurons. Neurons in the LHb displayed
a clear preference for VGAT+ neurons in the VTA, though they
did not entirely avoid dopamine or glutamate cells. Also notable,
VGAT+ neurons received proportionally more input from the lat-
erodorsal tegmental nucleus (LDTg) and raphe magnus nucleus
(RMg). Many other regions also provide input to VTA, though no
other regions represented >1% of the total input; for a detailed
list of regions and percentages of inputs, see Data S1.
Immunochemical Characterization of VTA Afferents by
Cell Type
The largest source of VTA input from the telencephalon was from
the ventral pallidum (VP), providing 6.1% ± 1.5%, 5.3% ± 0.5%,
(legend on next page)
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and 4.3% ± 0.3% of total input to VTA dopamine, glutamate, and
GABA neurons, respectively. The VP is composed principally of
GABAergic projection neurons (Root et al., 2015), a sub-popula-
tion of which label for the calcium-binding protein parvalbumin
(PV). We labeled sections through the VP for PV and quantified
the fraction of Rb-mCherry-labeled cells that co-label for PV.
Though not reaching statistical significance in our small sample
size, VTA dopamine neurons tend to receivemore input from PV-
labeled cells per starter neuron (Figure 6A), suggesting that PV
neurons may play a specialized role in the control of dopamine
neurons.
The largest two inputs to the VTA were from the DR and LH,
and from these regions, we observed no significant difference
by transmitter-defined cell type (Figure 4C). However, the DR
and LH are composed of heterogeneous populations of projec-
tion neurons, and subpopulations of neurons may preferentially
target transmitter-defined VTA neurons. In the LH, we character-
ized two subpopulations of neurons using the peptide markers
melanocortin-concentrating hormone (MCH) and orexin (also
called hypocretin), each of which labeled only a small fraction
of Rb+ VTA inputs from LH. The number of orexin co-labeled
LH inputs per VTA starter cell was greater in the VGLUT2-Cre
and DAT-Cre compared to VGAT-Cre mice (Figure 6B). In the
case of MCH, a lower ratio of Rb/MCH inputs per starter cell
was also observed for the VTA GABA population but again did
not reach statistical significance (Figure 6B).
As noted earlier, VTA dopamine neurons received a smaller
fraction of their inputs from the PPTg and LDTg when compared
to glutamate and especially GABA neurons (Figure 4C). The
PPTg and LDTg are well-known sources of cholinergic projection
neurons, though GABA and glutamate neurons are also abun-
dant, cholinergic neurons represent 25% of the total (Wang
and Morales, 2009). However, the number of Rb-mCherry+ cells
co-positive for ChAT did not differ as a function of starter cells
(Figure S4A). The DR was the largest single source of inputs to
the VTA in our study. Known best for its serotonin neurons, the
DR and median raphe (MnR) also contain large populations of
GABA and glutamate projection neurons (Gocho et al., 2013).
We therefore labeled for TpH to identify the proportion of seroto-
nergic inputs by VTA cell type (Figure S4B), though no significant
differences were observed.
DISCUSSION
Using classical tracers, neuroanatomists have described VTA
connectivity to and from a multitude of brain regions (Bjo¨rklund
and Dunnett, 2007; Carr and Sesack, 2000; Fields et al., 2007;
Geisler and Zahm, 2005; Ikemoto, 2007; Phillipson, 1979; Swan-Figure 3. Inputs to Transmitter-Defined VTA Cells Normalized by Start
(A–G) Example coronal images showing Rb-mCherry+ (red) input cells to transmi
represent animals and lines are linear regressions. ac, anterior commissure; PrL
BST, bed nucleus of the stria terminalis; VP, ventral pallidum;MCPO,magnocellula
LHb, lateral habenular nucleus; LH, lateral hypothalamus; PVH, paraventricular
tegmental nucleus; PB, parabrachial nucleus; LC, locus coeruleus; Aq, aqueduc
background autofluorescence (F and G). Scale bars represent 500 mm (B, C, E, a
(H) Histogram representing ratio of input cell numbers relative to starter cell counts
*p < 0.05, **p < 0.01.
2802 Cell Reports 15, 2796–2808, June 21, 2016son, 1982). However, aswe begin to appreciate the physiological
and behavioral relevance of VTA heterogeneity in behavior and
disease (Fields et al., 2007; Lammel et al., 2014; Volman et al.,
2013), it becomes crucial to understand how heterogeneous
VTA cell types are controlled via afferent connectivity. Modern
tracing vectors coupled with mouse genetics make it possible
to subsect across various dimensions of heterogeneity and trace
connections; indeed, two recent studies have focused on pro-
jection target-defined VTA dopamine neurons (Beier et al.,
2015; Menegas et al., 2015). However, the VTA also contains
sizable populations of GABA and glutamate-releasing neurons
that play discrete roles in regulating reward-related processes.
In this study, we provide a comprehensive description of inputs
to each of these neurotransmitter-defined VTA cell types. To our
surprise, we found that each of these transmitter-defined popu-
lations receive qualitatively similar afferent input. Nonetheless,
quantitative differences were observed, with glutamate neurons
tending to receive proportionally more input from cortical re-
gions, dopamine neurons frombasal ganglia, andGABA neurons
from the lateral habenula and LDTg. Further, comparing the ratio
of inputs to starter cells reveals that inputs to VTAGABA neurons
show more convergence, consistent with a more uniform model
of afferent control.
The most pronounced finding in our study is that the organi-
zation of afferent input to VTA is qualitatively independent of
transmitter-defined VTA cell type. This is counter to our initial
hypothesis that excitatory, inhibitory, and neuromodulatory
VTA cell types that convey distinct types of reward-relevant in-
formation might receive highly distinctive patterns of afferent
input. However, our results are generally concordant with recent
studies using similar approaches to compare the inputs to dopa-
mine neurons defined by their projection target. Those studies
did identify some distinctive connections to subpopulations of
dopamine neurons that target the lateral NAc (Beier et al.,
2015) or posterior striatum (Menegas et al., 2015) but overall indi-
cated that inputs to projection-target defined VTA dopamine
neurons were quite similar.
Though qualitative similarity was the rule, we did identify
several significant quantitative differences. For example, though
the cortex provides a proportionally small and diffuse input to
VTA, cortical regions as a whole make more inputs per starter
cell on to VTA glutamate neurons. These inputs come from a
variety of cortical regions, predominantly the somatosensory,
motor, insular, and cingulate cortices. That proportionally few
input cells were observed in cortical regions appears to be
compatible with earlier whole-brain quantitative approaches
(Geisler and Zahm, 2005; Phillipson, 1979). The small number
of input cells observed in the anterior cortex could be interpreteder Cell Counts
tter-defined VTA cells from select brain regions. Scatterplots: individual points
, prelimbic cortex; CPu, caudate putamen; AcbSh, nucleus accumbens shell;
r preoptic nucleus; LPO, lateral preoptic area; MHb,medial habenular nucleus;
nucleus of the hypothalamus; DR, dorsal raphe nucleus; LDTg, laterodorsal
t; scp, superior cerebellar peduncle. Blue contrast represents DAPI (A–E) or
nd F) and 250 mm (A, D, and G).
for the three genetically defined VTA cell type acrossmajor brain areas (±SEM);
Figure 4. Inputs to Transmitter-Defined VTA Neurons Normalized to Total Inputs
(A) Percentages of total inputs per major brain area across transmitter-defined cell types (±SEM).
(B) Schematic of input weights by major brain area; areas of circles are proportional to fraction of total inputs coming from each brain area.
(C) Percentages of total inputs per sub-area or region, with the top 25 inputs represented (±SEM).
(D) Color-coded schematic of input weights by sub-area or region representing the percentages of total inputs per regions for each VTA cell type. Regions or
sub-areas accounting for <1% of total input are not included in this representation. See Figure S3 for brain region key and Data S1 for detailed counts. *p < 0.05,
**p < 0.01, ***p < 0.001.in different ways: (1) cortical inputs may be relatively less influen-
tial than subcortical inputs to VTA, (2) relatively few cortical neu-
rons could make strong or large numbers of synapses, and(3) cortico-VTA synapses may be less efficiently labeled using
our tracing strategy. Indeed, the high sensitivity of Rb-based
approaches may lead to overweighting the implied influenceCell Reports 15, 2796–2808, June 21, 2016 2803
Figure 5. Differential Analysis of Inputs to Transmitter-Defined VTA Cell Types
Data normalized to total inputs and assessed by negative binomialmodels and the DESeq package. Analysis allowing for comprehensive pairwise comparisons is
represented here as fold differences (on a log scale) in weighted inputs relative to the other VTA cell types (±SEM). For a detailed description, see Supplemental
Experimental Procedures and Tables S1–S6. *p < 0.05.of afferent regions that contain many connected cells with
low synaptic incidence, whereas regions that may contain
fewer connected cells but with high synaptic incidence, or
making synapses resistant to transsynaptic spread, could be
underweighted.
We also find that basal ganglia nuclei, including the shell and
core regions of the NAc as well as the dorsal striatum (CPu)
and external globus pallidus (LGP), each provide proportionally
more input to dopamine compared to non-dopamine VTA neu-
rons. This finding is in apparent contradiction to optogenetic cir-
cuit-mapping studies that found that NAc projection neurons
preferentially target non-dopamine VTA neurons (Bocklisch
et al., 2013; Xia et al., 2011). It is possible that the NAc to VTA
dopamine projections we and others have identified anatomi-
cally (Beier et al., 2015; Bolam and Smith, 1990; Grace and
Bunney, 1985; Lerner et al., 2015; Menegas et al., 2015;
Watabe-Uchida et al., 2012) synapse on to distal dopamine den-
drites absent in the horizontal slice preparations, differ across
species, or are primarily peptidergic.
VGAT+ neurons in the VTA also display several distinct fea-
tures when compared to DAT+ and VGLUT2+ neighbors. First,2804 Cell Reports 15, 2796–2808, June 21, 2016they tend to receive more convergent input, i.e., fewer input cells
per starter cell whenmore starter cells are labeled. This suggests
that afferent control over VTA GABA neurons is more homoge-
nous, and consequently, GABA output may function in a more
uniform manner. Indeed, we also report here that VTA GABA
neurons receive proportionally more input from the LHb.
Although we find that LHb does not entirely avoid VTA dopamine
and glutamate neurons, this finding is very much consistent with
current models where LHb functionally inhibits VTA dopamine
neurons through feed-forward activation of GABA neurons (Bal-
cita-Pedicino et al., 2011; Brinschwitz et al., 2010; Proulx et al.,
2014). We also observed a proportionally larger input from the
LDTg to VTA GABA neurons, which is interesting in light of the
observation that photostimulation of a mixed LDTg input to
VTA was sufficient to drive a dopamine-dependent conditioned
place preference (Lammel et al., 2014), potentially highlighting
that the proportional weight of an input region need not correlate
with functional importance.
The most abundant inputs irrespective of cell type were from
DR, LH, and ventral pallidum. We used immunohistochemical
approaches to immunochemically identify subpopulations of
Figure 6. Immunohistochemical Characterization of Afferent Inputs
to VTA from Ventral Pallidum and LH
(A) Quantification of pallidal parvalbumin (PV)-expressing afferents to trans-
mitter-defined VTA cell types. Histogram represents the ratio of Rb-mCherry+
cells immunolabeled with anti-PV in the ventral pallidum (VP) relative to the
number of starter cells (±SEM).
(B) Quantification of hypothalamic orexin-expressing and melanocortin
concentrating hormone (MCH)-expressing afferents to VTA cell types. Histo-cells within these and other select regions for peptidemarkers as
well as enzymatic markers indicative of serotonin or acetylcho-
line biosynthesis. Although orexin+ and MCH+ inputs from LH
tended to preferentially target non-GABA neurons in the VTA
and PV+ neurons may have preferentially targeted dopamine
neurons, these observations did not reach statistical significance
once corrected for multiple comparisons. This highlights impor-
tant limitations of our study and previous studies using similar
approaches to quantitatively compare VTA inputs: low sample
size, large numbers of measurements, and consequently low
statistical power for group comparisons. The VTA receives in-
puts from a large number of brain regions, and thus several hun-
dred measurements are made per group; these measurements
range across several orders of magnitude, limiting the utility of
statistical tests that rely on normality. We thus limited our quan-
titative assessments to two approaches. One-way ANOVAs
were used to compare the three genotypes within equi-variant
regions followed by a Tukey post hoc correction for multiple
comparisons. This approach applies separate ANOVAs across
each brain region and fails to consider the dataset in its entirety.
Because of the small sample size and large number of compar-
isons, we also applied methods developed to probe changes
in gene expression across groups (Love et al., 2014). This
approach leverages information across region in estimating the
parameters of negative binomial generalized linear models fit
to each region. This analysis, represented in Figure 5 (see also
the Supplemental Experimental Procedures and Tables S1–
S6), allows for pairwise comparisons of inputs across region
and cell type and produced results highly concordant with
ANOVA.
Beier et al. (2015) recently published a report comparing inputs
to VTA dopamine versus GABA neurons. Although the overall
pattern and respective weights of the afferents were similar
across our studies, there are several notable differences. As dis-
cussed above, we find that striatal regions preferentially target
dopamine neurons while GABA neurons receive proportionally
more input from LHb and LDTg, whereas the previous study
reported no significant differences between these cell types.
Several methodological differences could contribute to this,
including our use of different Cre-driver lines, viral serotypes,
and promoters or differences in the number and location of
starter cells. Potentially relating to the latter is our strategy of
injecting AAV-TVA helper virus diluted by two to three orders
of magnitude compared to previous studies targeting VTA cell
types. We adopted this strategy to limit the potential for low-level
expression of TVA outside of the VTA due to spread or retrograde
transport of AAV or outside of the cell type of interest due to a
leak in TVA expression from the DIO cassette. Indeed, although
the pseudotyped Rb vector we used produced no detectablegrams represent the ratio of Rb-mCherry+ cells immunolabeled with anti-
orexin (top) or anti-MCH (bottom) in the lateral hypothalamus (LH) relative to
the number of starter cells (±SEM). Points in scatterplots represent individual
animals and lines are linear regressions. Example coronal images for each
genotype show Rb-mCherry expression (red) along with immunostaining
(green) against PV, orexin, or MCH.
Arrows represent co-localizing cells. Scale bar represents 200 mm. See also
Figure S4.
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mCherry expression when injected into mice not previously in-
jected with helpers, copious mCherry+ cells were present at
the injection site in wild-type mice (lacking Cre) previously in-
jected with ‘‘stock’’ concentrations (i.e., >1012) of helper AAVs.
That we did not find Rb-mCherry expression at sites distal to
the VTA or evidence of TVA:YFP or RbG-BFP fluorescence
within the VTA suggests that very low-level Cre-independent
‘‘leak’’ expression of TVA:YFP suffices for entry of pseudo-typed
Rb-mCherry but that higher Cre-dependent expression of RbG is
required for transsynaptic spread (Miyamichi et al., 2013; Weiss-
bourd et al., 2014). By selecting a highly diluted concentration of
AAV-TVA, we minimized the potential for primary infection by
Rb-mCherry in Cre-negative cells and increased the proportion
of starter cells restricted to the VTA. However, this strategy
also reduces the total number of starter cells that may introduce
greater sampling bias. Another difference between our approach
and that taken in prior studies is our use of a bicistronic AAV
helper vector to express histone-bound (i.e., nuclear) FLAG-
tagged BFP in RbG-expressing cells. Because it is the expres-
sion of the RbG that allows for transsynaptic spread, any neuron
expressing Rb-mCherry and RbG-BFP will function as a starter
cell, whether or not it expresses TVA or was infected by primary
(i.e., injected Rb-mCherry) or subsequently by Rb-mCherry
amplified in vivo.
Using this approach, we were able to target an equivalent
number of starter cells for each of the three cell types. Though
our injections were medially biased to focus on the VGLUT2+
population, these results suggest that the relative proportions
of these cell types, especially in medial VTA, may be more
balanced than generally appreciated. Indeed, estimates of
VGLUT2+ VTA cells vary greatly depending on the approach
used (Kawano et al., 2006; Nair-Roberts et al., 2008; Yamaguchi
et al., 2011), and Cre-dependent AAV-mediated expression may
be particularly sensitive to low expression levels. Additionally,
the ability of VTA neurons to co-releasemultiple transmitters dic-
tates that some cells will be represented in more than one group.
In this study, we found that 18.4% ± 4.5% of VGLUT2+ starter
cells labeled for the dopamine neuron marker TH, likely contrib-
uting to the similarity between inputs received on to DAT+ and
VGLUT2+ cell types. Dopamine neurons can also co-release
GABA, but GABA co-release relies on non-canonical mecha-
nisms of GABA synthesis and vesicular packaging (Kim et al.,
2015; Tritsch et al., 2012), and we found that <1% of VGAT-
Cre starters co-labeled for TH. Selective labeling of and tracing
of inputs only to neurons that express both dopamine and gluta-
mate markers, or to glutamate, but not dopamine, markers,
would be of great interest but will require the development of
new mouse driver lines and viral vectors.
In summary, we showed that VTA glutamate, dopamine, and
GABA neurons receive qualitatively similar but quantitatively
distinct patterns of input from many and diverse brain regions.
Dopamine and GABA neurons show several marked differences,
while VGLUT2+ neurons are generally an intermediate between
the two, which is perhaps an expression of their ability to co-
release either dopamine or GABA. This work adds to our growing
body of knowledge on the input/output relationship of VTA cell
types and will be used to further unravel the functional impor-
tance of distinct mesolimbic sub-circuits. Understanding how2806 Cell Reports 15, 2796–2808, June 21, 2016distinct populations of anatomically and neurochemically distinct
circuits are connected to control behavior promises to provide
opportunities to treat intractablemental illness such as addiction.
EXPERIMENTAL PROCEDURES
Animals
Both male and female mice were included, and all experiments performed in
accordance with protocols approved by the University of California San Diego
Institutional Animal Care and Use Committee (IACUC). 200 nl of a 1:1 mixture
of AAV-TVAandAAV-RbGwas intracranially injected into the VTA, and 3weeks
later, 125 nl Rb-mCherry was injected at the same coordinates. Animals were
transcardially perfused with 4% paraformaldehyde 7 days after Rb-mCherry
injection, and 30-mm coronal sections were collected for quantitative assess-
ment and immunostaining. See the Supplemental Experimental Procedures
for details.
Cell Counts
Counting of starter cells, afferent input cells, and immunohistochemically char-
acterized cells was conducted manually and blindly on one 30-mm section
every 150mmalong the rostral caudal extent of the brain. Cellswere considered
starters when clearly visible native cytoplasmic mCherry fluorescence and nu-
clear immunolabel against the FLAG epitope on RbG. TH was assessed on the
same sections and cells identified as TH positive when soma and cell pro-
cesses clearly overlapped for TH immunolabel and native mCherry. Neurons
were considered VTA afferent inputs when the red fluorescence (mCherry)
was filling objects that showed clear borders and processes. Regions were
identified by a single investigator using the PaxinosMouse Brain Atlas (Paxinos
and Franklin, 2001) and grouped into areas and sub-areas based on the Allen
Brain Atlas classification. For details on immunohistochemical characteriza-
tion, counting, and statistics, see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, six tables, and one dataset and can be found with this article on-
line at http://dx.doi.org/10.1016/j.celrep.2016.05.057.
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